| Date Filed | Type | Description |
| 08/18/2023 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Paid exercise price by delivering 15,976 shares
@ $0.693, valued at
$11.1k
|
|
| 07/05/2023 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Disposed/sold 168,237 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 15,750 options to buy
@ $8.7, valued at
$137k
Granted 4,660 restricted stock units
@ $0
Exercised 4,507 restricted stock units
@ $0 |
|
| 05/19/2023 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Societal CDMO, Inc.|
Txns:
| Granted 73,620 shares
@ $0
Granted 27,229 options to buy
@ $0.74, valued at
$20.1k
|
|
| 04/05/2023 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Granted 168,237 restricted stock units
@ $0 |
|
| 12/22/2022 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Granted 112,636 shares
@ $0 |
|
| 06/21/2022 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Disposed/sold 11,593 shares
@ $0
Disposed/sold 57,569 options to buy
@ $22.26, valued at
$1.3M
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Societal CDMO, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 118,182 options to buy
@ $0.8, valued at
$94.5k
|
|
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4/A
| Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 38,012 options to buy
@ $0 |
|
| 04/22/2021 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 26,923 shares
@ $0
Granted 38,012 options to buy
@ $1.71, valued at
$65k
|
|
| 12/07/2020 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Sold 5,400 shares
@ $0.165, valued at
$891 |
|
| 06/08/2020 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.41, valued at
$23.3k
Exercised 7,333 restricted stock units
@ $0 |
|
| 05/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2020 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Paid exercise price by delivering 986 shares
@ $1.93, valued at
$1.9k
|
|
| 03/04/2020 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 8,876 restricted stock units
@ $0
Exercised 8,876 restricted stock units
@ $0 |
|
| 12/09/2019 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 9,156 shares
@ $0 |
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Bought 5,400 shares
@ $8.9599, valued at
$48.4k
|
|
| 05/10/2019 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 7,955 shares
@ $0
Granted 10,888 options to buy
@ $8.8, valued at
$95.8k
|
|
| 04/03/2019 |
4
| Reasons Bryan M. (EVP & CFO) has filed a Form 4 on Mallinckrodt plc|
Txns:
| Granted 12,579 shares
@ $0
Granted 57,569 options to buy
@ $22.26, valued at
$1.3M
|
|
| 03/21/2019 |
3
| Reasons Bryan M. (EVP & CFO) has filed a Form 3 on Mallinckrodt plc |
| 08/23/2018 |
4
| Reasons Bryan M. (CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Sold 11,698 shares
@ $23.65, valued at
$276.7k
|
|
| 05/14/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2018 |
4/A
| Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 8,965 options to buy
@ $11.32, valued at
$101.5k
|
|
| 05/08/2018 |
4
| Reasons Bryan M. (CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 94,684 shares
@ $0
Granted 56,232 options
@ $9.35, valued at
$525.8k
Granted 63,095 options
@ $33.27, valued at
$2.1M
Granted 47,500 options
@ $40.7, valued at
$1.9M
Granted 55,000 options
@ $25.24, valued at
$1.4M
Granted 52,000 options
@ $17.99, valued at
$935.5k
Granted 136,240 options
@ $15.01, valued at
$2M
Granted 33,311 restricted stock units
@ $0 |
|
| 05/08/2018 |
3
| Reasons Bryan M. (CFO) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |
| 05/08/2018 |
4
| Reasons Bryan M. (Director) has filed a Form 4 on Recro Pharma, Inc.|
Txns:
| Granted 6,183 shares
@ $0
Granted 5,742 options to buy
@ $11.32, valued at
$65k
|
|
| 05/08/2018 |
4
| Reasons Bryan M. (CFO) has filed a Form 4 on Impax Laboratories, LLC|
Txns:
| Disposed/sold 53,423 shares
@ $0
Disposed/sold 20,566 shares
@ $0
Disposed/sold 56,232 options to buy
@ $9.35, valued at
$525.8k
Disposed/sold 63,095 options to buy
@ $33.27, valued at
$2.1M
Disposed/sold 47,500 options to buy
@ $40.7, valued at
$1.9M
Disposed/sold 55,000 options to buy
@ $25.24, valued at
$1.4M
Disposed/sold 52,000 options to buy
@ $17.99, valued at
$935.5k
|
|
| 04/23/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/23/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/05/2018 |
4
| Reasons Bryan M. (CFO) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 3,069 shares
@ $19.5, valued at
$59.8k
|
|
| 02/27/2018 |
4
| Reasons Bryan M. (CFO) has filed a Form 4 on IMPAX LABORATORIES INC|
Txns:
| Paid exercise price by delivering 6,141 shares
@ $20.95, valued at
$128.7k
|
|
|